Blog
RSS FeedPosted by Michael Wonder on 11 Jun 2018
SMC - June 2018 decisions
11 June 2018 - The SMC, has today published advice accepting six new medicines for use by NHSScotland. ...
Posted by Michael Wonder on 14 May 2018
The Scottish Medicines Consortium accepts use of Kyntheum (brodalumab) for eligible patients with moderate-to-severe plaque psoriasis
11 May 2018 - The SMC has issued advice accepting brodalumab 210 mg for restricted use within NHS Scotland. ...
Posted by Michael Wonder on 14 May 2018
Seven drugs available in England but not Scotland, Holyrood hears
11 May 2018 - Seven drugs to treat patients with a range of conditions from cancer to muscular dystrophy are ...
Posted by Michael Wonder on 10 May 2018
Call for Scottish breast cancer drug deal
10 May 2018 - Ruth Davidson has called for a deal to allow a breast cancer drug that is offered ...
Posted by Michael Wonder on 30 Apr 2018
Brexit diagnosis predicts drug delay for UK patients
28 April 2018 - One of Scotland’s leading neurologists has warned that Brexit will delay the newest life-saving drugs reaching ...
Posted by Michael Wonder on 09 Apr 2018
Five new medicines accepted by SMC for use by NHSScotland
9 April 2018 - The SMC, has today published advice accepting five new medicines for use by NHSScotland. ...
Posted by Michael Wonder on 25 Mar 2018
Fresh hopes that breast cancer drug Perjeta will be made available in Scotland
22 March 2018 - Breast cancer campaigners have welcomed talks aimed at making a life-extending drug available to women in ...
Posted by Michael Wonder on 21 Mar 2018
Using real world data in health technology assessment (HTA) practice: a comparative study of five HTA agencies
21 March 2018 - This study examines whether real world data is incorporated in health technology assessment (HTA) of melanoma drugs ...
Posted by Michael Wonder on 14 Mar 2018
Breast cancer drug approved for NHS use
13 March 2018 - The use of new drugs to treat breast cancer and Hodgkin’s lymphoma has been approved, bringing Scottish ...
Posted by Michael Wonder on 13 Mar 2018
Analysis: new drug decisions and NHS spending conundrums
12 March 2018 - The latest round of drug decisions from the Scottish Medicines Consortium throws up the usual mix ...
Posted by Michael Wonder on 13 Mar 2018
SMC - March 2018 decisions
12 March 2018 - SMC accepts new medicines for breast cancer and Hodgkin’s lymphoma for use by NHSScotland ...
Posted by Michael Wonder on 20 Feb 2018
SMC approves NHS funding for UCB’s Vimpat in children
20 February 2018 - Children living in Scotland with epilepsy will get NHS-funded treatment with UCB’s Vimpat following a green ...
Posted by Michael Wonder on 12 Feb 2018
Scots patients with advanced bladder cancer get first new drug for 25 years after SMC approves pembrolizumab
12 February 2018 - Bladder cancer patients whose tumours have spread are set to get a new drug on the ...
Posted by Michael Wonder on 12 Feb 2018
SMC - February 2018 decisions
12 February 2018 - Medicines for bladder cancer, skin cancer and multiple sclerosis among five new treatments accepted for use ...
Posted by Michael Wonder on 15 Jan 2018
Scottish Medicines Consortium rejects cancer drugs for routine use on NHS
15 January 2018 - Drugs used to treat two rare cancers have been turned down for routine use by the ...